Xinyuan Ding

661 total citations
29 papers, 401 citations indexed

About

Xinyuan Ding is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Xinyuan Ding has authored 29 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Epidemiology. Recurrent topics in Xinyuan Ding's work include Ubiquitin and proteasome pathways (4 papers), Mesenchymal stem cell research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Xinyuan Ding is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Mesenchymal stem cell research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Xinyuan Ding collaborates with scholars based in China. Xinyuan Ding's co-authors include Wenjuan Wang, Min Jin, Yanyun Zhang, Mingxing Xue, Jiefang Huang, Zheng Wang, Caihong Tan, Yuting Gu, Kunwei Shen and Xiaosong Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS Biology and Journal of Hepatology.

In The Last Decade

Xinyuan Ding

27 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinyuan Ding China 12 243 86 81 53 42 29 401
Elena Navarro‐Villarán Spain 10 224 0.9× 101 1.2× 42 0.5× 56 1.1× 70 1.7× 17 397
Marjaneh Farazestanian Iran 7 243 1.0× 133 1.5× 92 1.1× 60 1.1× 35 0.8× 23 402
Junfang Lyu Macao 11 258 1.1× 107 1.2× 91 1.1× 24 0.5× 34 0.8× 14 384
Weixue Tang China 13 278 1.1× 160 1.9× 90 1.1× 64 1.2× 75 1.8× 38 507
Raquel Pluvinet Spain 11 243 1.0× 99 1.2× 56 0.7× 27 0.5× 83 2.0× 19 434
Ziyun Shao China 10 358 1.5× 220 2.6× 105 1.3× 40 0.8× 64 1.5× 13 593
Zheng Wei China 10 195 0.8× 68 0.8× 77 1.0× 29 0.5× 53 1.3× 21 427
Sook In Chung South Korea 11 198 0.8× 61 0.7× 54 0.7× 84 1.6× 24 0.6× 17 377
Tuğsan Tezil Türkiye 11 269 1.1× 49 0.6× 60 0.7× 47 0.9× 34 0.8× 13 372
Min Guo China 13 244 1.0× 154 1.8× 79 1.0× 66 1.2× 74 1.8× 28 447

Countries citing papers authored by Xinyuan Ding

Since Specialization
Citations

This map shows the geographic impact of Xinyuan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyuan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyuan Ding more than expected).

Fields of papers citing papers by Xinyuan Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyuan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyuan Ding. The network helps show where Xinyuan Ding may publish in the future.

Co-authorship network of co-authors of Xinyuan Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyuan Ding. A scholar is included among the top collaborators of Xinyuan Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyuan Ding. Xinyuan Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Xinyuan, et al.. (2025). Associations between sepsis occurrence, hemoglobin level and mortality in patients with non-trauma hemorrhagic brain injuries: trajectory-based analysis. European journal of medical research. 30(1). 155–155. 1 indexed citations
2.
Ding, Xinyuan, Guolong Cai, Li Zhu, et al.. (2025). Non-linear associations between renal perfusion pressure indexes and AKI incidence and recovery rate. European journal of medical research. 30(1). 383–383.
3.
Qiu, Yajing, et al.. (2025). Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response. PLoS Biology. 23(7). e3003284–e3003284. 1 indexed citations
4.
Jin, Min, Yuting Gu, Xiaonan Zhao, et al.. (2024). Intracellular osteopontin potentiates the immunosuppressive activity of mesenchymal stromal cells. Stem Cell Research & Therapy. 15(1). 366–366.
5.
Xie, Linjun, Lian Tang, Wenjuan Wang, et al.. (2023). A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China. BMC Health Services Research. 23(1). 771–771. 3 indexed citations
6.
Huang, Shungen, et al.. (2022). Cathepsin L promotes chemresistance to neuroblastoma by modulating serglycin. Frontiers in Pharmacology. 13. 920022–920022. 4 indexed citations
8.
Wang, Zheng, Fan Wang, Xinyuan Ding, et al.. (2021). Hippo/YAP signaling choreographs the tumor immune microenvironment to promote triple negative breast cancer progression via TAZ/IL-34 axis. Cancer Letters. 527. 174–190. 41 indexed citations
9.
Li, Jianhua, Lian Tang, Xin Liu, et al.. (2021). The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis. Frontiers in Oncology. 11. 629640–629640. 8 indexed citations
10.
Yang, Wanlin, Jiefang Huang, Miao Xiang, et al.. (2021). GPR120 induces regulatory dendritic cells by inhibiting HK2-dependent glycolysis to alleviate fulminant hepatic failure. Cell Death and Disease. 13(1). 1–1. 33 indexed citations
11.
Tang, Lian, Xinyuan Ding, Lan Li, et al.. (2021). A Regression Model to Predict Augmented Renal Clearance in Critically Ill Obstetric Patients and Effects on Vancomycin Treatment. Frontiers in Pharmacology. 12. 622948–622948. 6 indexed citations
12.
Wang, Mei, Xinyuan Ding, Huan Gui, et al.. (2020). Triterpenoid saponins from Ilex cornuta protect H9c2 cardiomyocytes against H2O2-induced apoptosis by modulating Ezh2 phosphorylation. Journal of Ethnopharmacology. 269. 113691–113691. 14 indexed citations
13.
Yao, Xinyu, et al.. (2020). The effect of body mass index and creatinine clearance on serum trough concentration of vancomycin in adult patients. BMC Infectious Diseases. 20(1). 341–341. 9 indexed citations
14.
Ding, Xinyuan, Yuting Gu, Min Jin, et al.. (2020). The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase. Theranostics. 10(13). 6048–6060. 34 indexed citations
15.
Wu, Wei, Ziyan Wang, Xing Jin, et al.. (2020). USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway. Frontiers in Pharmacology. 11. 668–668. 29 indexed citations
16.
Wang, Wenjuan, Yajie Xiong, Xinyuan Ding, et al.. (2019). Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC. Journal of Experimental & Clinical Cancer Research. 38(1). 61–61. 40 indexed citations
17.
Gu, Yuting, Yiji Cheng, Bing Wan, et al.. (2018). A pivotal role of BEX1 in liver progenitor cell expansion in mice. Stem Cell Research & Therapy. 9(1). 164–164. 8 indexed citations
18.
Gu, Yuting, Mingxing Xue, Kai Chen, et al.. (2018). The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation. Journal of Experimental & Clinical Cancer Research. 37(1). 258–258. 34 indexed citations
19.
Gu, Yuting, Xinyuan Ding, Jiefang Huang, et al.. (2018). The deubiquitinating enzyme UCHL1 negatively regulates the immunosuppressive capacity and survival of multipotent mesenchymal stromal cells. Cell Death and Disease. 9(5). 459–459. 38 indexed citations
20.
Zhang, J., Xinyuan Ding, Z Bian, et al.. (2009). The effect of anti-eppin antibodies on ionophore A23187-induced calcium influx and acrosome reaction of human spermatozoa. Human Reproduction. 25(1). 29–36. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026